ML-004 (IR)/(ER) tablet

Drug identity checked against registry records

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
ML-004 in Adolescents and Adults With Autism Spectrum Disorders (ASD)NCT05081245MapLight TherapeuticsPhase 2Completed2026-03-10Actual
ML-004 Open-Label Extension Study in Adults and Adolescents With Autism Spectrum Disorders (ASD)NCT05889273MapLight TherapeuticsPhase 2Active not recruiting2027-11Estimated

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.